rs10922153

Variant names:

• chr1-197009485-T-G
• rs10922153
• NM_030787.4:c.*802T>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_Strong BP6_Very_Strong BA1

The NM_030787.4(CFHR5):​c.*802T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.383 in 152,060 control chromosomes in the GnomAD database, including 12,795 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

• Frequency:
  • Genomes: 𝑓 0.38 (12795 hom., cov: 31)
  • Failed GnomAD Quality Control
• Consequence: CFHR5 NM_030787.4 3_prime_UTR
• Clinical Significance: Benign criteria provided, multiple submitters, no conflicts B:2
• Conservation: PhyloP100: 1.55
• Publications: 18 publications found

Genes affected

CFHR5 (HGNC:24668): (complement factor H related 5) This gene is a member of a small complement factor H (CFH) gene cluster on chromosome 1. Each member of this gene family contains multiple short consensus repeats (SCRs) typical of regulators of complement activation. The protein encoded by this gene has nine SCRs with the first two repeats having heparin binding properties, a region within repeats 5-7 having heparin binding and C reactive protein binding properties, and the C-terminal repeats being similar to a complement component 3 b (C3b) binding domain. This protein co-localizes with C3, binds C3b in a dose-dependent manner, and is recruited to tissues damaged by C-reactive protein. Allelic variations in this gene have been associated, but not causally linked, with two different forms of kidney disease: membranoproliferative glomerulonephritis type II (MPGNII) and hemolytic uraemic syndrome (HUS). [provided by RefSeq, Jan 2010]

CFHR5 Gene-Disease associations (from GenCC):

• C3 glomerulonephritis

  Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

ACMG classification

Our verdict: Benign. The variant received -20 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.89).
• BP6: Variant 1-197009485-T-G is Benign according to our data. Variant chr1-197009485-T-G is described in ClinVar as Benign. ClinVar VariationId is 294562.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
• BA1: GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.507 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_030787.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	CFHR5	NM_030787.4	MANE Select	c.*802T>G		3_prime_UTR	Exon 10 of 10	NP_110414.1

Ensembl Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	CFHR5	ENST00000256785.5	TSL:1 MANE Select	c.*802T>G		3_prime_UTR	Exon 10 of 10	ENSP00000256785.4
	CFHR5	ENST00000699466.1		c.*802T>G		downstream_gene	N/A	ENSP00000514393.1
	CFHR5	ENST00000699468.1		c.*802T>G		downstream_gene	N/A	ENSP00000514394.1

Frequencies

GnomAD3 genomes AF: 0.383 AC: 58231 AN: 151942 Hom.: 12785 Cov.: 31

Gnomad AFR AF: 0.192

Gnomad AMI AF: 0.753

Gnomad AMR AF: 0.343

Gnomad ASJ AF: 0.406

Gnomad EAS AF: 0.129

Gnomad SAS AF: 0.377

Gnomad FIN AF: 0.455

Gnomad MID AF: 0.418

Gnomad NFE AF: 0.511

Gnomad OTH AF: 0.388

GnomAD4 exome Data not reliable, filtered out with message: AC0 AC: 0 AN: 0 Hom.: 0 Cov.: 0 AC XY: 0 AN XY: 0

African (AFR) AC: 0 AN: 0

American (AMR) AC: 0 AN: 0

Ashkenazi Jewish (ASJ) AC: 0 AN: 0

East Asian (EAS) AC: 0 AN: 0

South Asian (SAS) AC: 0 AN: 0

European-Finnish (FIN) AC: 0 AN: 0

Middle Eastern (MID) AC: 0 AN: 0

European-Non Finnish (NFE) AC: 0 AN: 0

Other (OTH) AC: 0 AN: 0

GnomAD4 genome AF: 0.383 AC: 58252 AN: 152060 Hom.: 12795 Cov.: 31 AF XY: 0.377 AC XY: 28008 AN XY: 74306

African (AFR) AF: 0.192 AC: 7951 AN: 41496

American (AMR) AF: 0.343 AC: 5233 AN: 15278

Ashkenazi Jewish (ASJ) AF: 0.406 AC: 1410 AN: 3472

East Asian (EAS) AF: 0.128 AC: 662 AN: 5174

South Asian (SAS) AF: 0.379 AC: 1825 AN: 4818

European-Finnish (FIN) AF: 0.455 AC: 4794 AN: 10536

Middle Eastern (MID) AF: 0.418 AC: 123 AN: 294

European-Non Finnish (NFE) AF: 0.511 AC: 34750 AN: 67974

Other (OTH) AF: 0.389 AC: 822 AN: 2112

Alfa AF: 0.483 Hom.: 32014

Bravo AF: 0.366

Asia WGS AF: 0.253 AC: 880 AN: 3478

ClinVar

ClinVar submissions as Germline

Significance: Benign

Revision: criteria provided, multiple submitters, no conflicts

Pathogenic	VUS	Benign	Condition
-	-	1	CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II (1)
-	-	1	not provided (1)

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.89
CADD	Benign	4.6
DANN	Benign	0.55
PhyloP100		1.6
Mutation Taster		=100/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs10922153; hg19: chr1-196978615; COSMIC: COSV56819761;